Main Management LLC - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.

Quarter-by-quarter ownership
Main Management LLC ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q3 2023$1,752
-10.6%
65,0940.0%0.18%
-10.6%
Q2 2023$1,960
+6.1%
65,094
+14.0%
0.20%
+1.5%
Q1 2023$1,847
+10.7%
57,094
-1.9%
0.20%
+2.1%
Q4 2022$1,668
-99.1%
58,194
+627.4%
0.19%
+700.0%
Q3 2022$193,000
-83.4%
8,000
-81.2%
0.02%
-82.7%
Q2 2022$1,166,000
-21.2%
42,600
+10.4%
0.14%
-9.2%
Q1 2022$1,480,000
+19.7%
38,6000.0%0.15%
+23.4%
Q4 2021$1,236,000
-13.7%
38,600
-20.6%
0.12%
-19.5%
Q3 2021$1,432,000
+321.2%
48,600
+386.0%
0.15%
+316.2%
Q2 2021$340,000
-22.6%
10,000
-25.9%
0.04%
-24.5%
Q1 2021$439,000
+143.9%
13,500
+170.0%
0.05%
+113.0%
Q4 2020$180,000
-54.1%
5,000
-50.0%
0.02%
-58.2%
Q3 2020$392,000
-66.0%
10,000
-80.0%
0.06%
-74.2%
Q1 2020$1,152,000
-92.4%
50,000
-90.3%
0.21%
-89.5%
Q4 2019$15,146,000
+8.3%
517,277
-1.2%
2.04%
+4.8%
Q3 2019$13,982,000
+994.1%
523,486
+947.0%
1.94%
+944.6%
Q2 2019$1,278,000
+14.0%
50,0000.0%0.19%
+12.7%
Q1 2019$1,121,000
+6.3%
50,0000.0%0.16%
+2.5%
Q4 2018$1,055,00050,0000.16%
Other shareholders
VANECK VECTORS ETF TR shareholders Q3 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$20,220,00066.82%
Baymount Management LP 145,000$3,970,00028.08%
New Harbor Financial Group, LLC 1,371,341$37,547,00018.51%
New Harbor Financial Group, LLC 1,291,700$35,366,00017.44%
MKP Capital Management, L.L.C. 1,500,000$41,070,00013.74%
Windmill Hill Asset Management Ltd 844,600$23,125,00011.94%
Hollow Brook Wealth Management LLC 768,567$21,043,00011.57%
Grand Central Investment Group 261,915$7,171,00010.33%
Point72 Europe (London) LLP 1,467,000$40,166,0008.50%
Slate Path Capital LP 4,600,000$125,948,0007.87%
View complete list of VANECK VECTORS ETF TR shareholders